tiprankstipranks
Elite Pharmaceuticals (ELTP)
:ELTP
US Market

Elite Pharmaceuticals (ELTP) Financial Statements

Compare
293 Followers

Elite Pharmaceuticals Financial Overview

Elite Pharmaceuticals's market cap is currently $520.73M. The company's EPS TTM is $-0.016; its P/E ratio is ―; Elite Pharmaceuticals is scheduled to report earnings on February 17, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue$ 56.63M$ 34.16B$ 32.26M$ 25.38M$ 17.99M
Gross Profit$ 26.36M$ 16.59B$ 14.80M$ 11.87M$ 7.98M
Operating Income$ 10.79M$ 2.03B$ 5.07M$ 2.10M$ -2.29M
EBITDA$ 2.58M$ 6.43M$ 6.27M$ 5.93M$ -371.88K
Net Income$ 20.11M$ 4.41B$ 8.90M$ 5.09M$ -2.24M
Balance Sheet
Cash & Short-Term Investments$ 7.11M$ 7.83M$ 8.54M$ 3.19M$ 1.13M
Total Assets$ 83.65M$ 40.90M$ 35.15M$ 26.19M$ 24.96M
Total Debt$ 11.74M$ 3.89M$ 2.78M$ 2.38M$ 4.03M
Net Debt$ 4.63M$ -3.94M$ -5.75M$ -814.26K$ 2.90M
Total Liabilities$ 26.07M$ 11.94M$ 9.93M$ 10.04M$ 14.30M
Stockholders' Equity$ 57.58M$ 28.96M$ 25.22M$ 16.15M$ 10.66M
Cash Flow
Free Cash Flow$ -4.09M$ -2.40M$ 6.01M$ 2.86M$ -1.83M
Operating Cash Flow$ -3.28M$ 3.34M$ 6.51M$ 3.19M$ -1.79M
Investing Cash Flow$ -809.65K$ -5.74M$ -498.57K$ -262.78K$ -34.95K
Financing Cash Flow$ 3.39M$ 1.70M$ -667.13K$ -869.83K$ 689.54K
Currency in USD

Elite Pharmaceuticals Earnings and Revenue History

Elite Pharmaceuticals Debt to Assets

Elite Pharmaceuticals Cash Flow

Elite Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis